生长板调控分子遗传特征与体格发育障碍

何玺玉; 和秀梅

doi:10.11852/zgetbjzz2022-0852

PDF(941 KB)

中国儿童保健杂志 ›› 2022, Vol. 30 ›› Issue (9) : 929-932. DOI: 10.11852/zgetbjzz2022-0852

专家笔谈

生长板调控分子遗传特征与体格发育障碍

何玺玉, 和秀梅

作者信息 +

Molecular genetic characteristics of growth plate regulation and physical development disorder

HE Xi-yu, HE Xiu-mei

Author information +

文章历史 +

摘要

儿童体格的线性生长是通过对生长板软骨细胞增殖、分化实现的,生长板软骨细胞功能受软骨细胞内信号通路、细胞外基质、生长激素-胰岛素样生长因子轴、生长板旁分泌因子调控及外在因素(营养摄入、炎性因子)的影响。成年终身高具有很大异质性,主要由遗传因素决定,涉及多个功能基因。生长相关基因变异导致生长板软骨细胞分化及增殖异常,是儿童生长障碍疾病的遗传病理机制,呈现广泛的临床表征谱。了解及明确体格发育障碍的遗传病因及机制,能够为精准治疗提供帮助。

Abstract

The linear growth of children's physique is realized by the proliferation and differentiation of growth plate chondrocytes. The function of growth plate chondrocytes is controlled by intracellular signal pathway, extracellular matrix, growth hormone-insulin-like growth factor axis, secretion factors beside growth plate and external factors (nutritional intake, inflammatory factors). Adult height has great heterogeneity, which is mainly determined by genetic factors and involves multiple functional genes. Growth-related gene variation leads to abnormal differentiation and proliferation of growth plate chondrocytes, which is the genetic and pathological mechanism of children's growth disorders, showing a wide spectrum of clinical manifestations. Understanding the genetic causes and mechanisms of physical development disorders can provide help for precise treatment.

导出引用

何玺玉, 和秀梅. 生长板调控分子遗传特征与体格发育障碍[J]. 中国儿童保健杂志. 2022, 30(9): 929-932 https://doi.org/10.11852/zgetbjzz2022-0852

HE Xi-yu, HE Xiu-mei. Molecular genetic characteristics of growth plate regulation and physical development disorder[J]. Chinese Journal of Child Health Care. 2022, 30(9): 929-932 https://doi.org/10.11852/zgetbjzz2022-0852

中图分类号： R179

参考文献

[1] Lui JL, Presley G, Jeffrey B. Regulation of body growth[J]. Curr Opin Pediatr,2015,27(4):502-510.
[2] D Joe M. Nutrition, infection and stunting: The roles of deficiencies of individual nutrients and foods, and of inflammation, as determinants of reduced linear growth of children[J]. Nutr Res Rev,2017,30(1):50-72.
[3] Butler AA,Le Roith D. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles[J]. Annu Rev Physiol,2001,63:141-164.
[4] Martin OS, Christine PB, Ron GR. The continuum of growth hormone-IGF-l axis defects causing short stature: Diagnostic and therapeutic challenges[J]. Clin Endocrinol,2010,72(6):721-728.
[5] Youn HJ,Anenisia CA,Jeffrey B, et al. Genetics of short stature[J]. Endocrinol Metab Clin North Am,2017,46(2):259-281.
[6] Youn HJ,Jeffrey B,Ola N. New developments in the genetic diagnosis of short stature[J]. Curr Opin Pediatr,2018,30(4):541-547.
[7] Rosenbloom AL. Idiopathic short stature: Conundrums of definition and treatment[J]. Int J Pediatr Endocrinol, 2009, 2009(1):470378.
[8] Jeffrey B, Lars S, Francesco DL, et al. Short and tall stature: A new paradigm emerges[J]. Nat Rev Endocrinol,2015,11(12):735-746.
[9] Farnum CE, Lee R, O'Hara K, et al. Volume increase in growth plate chondrocytes during hypertrophy: The contribution of organic osmolytes[J]. Bone, 2002, 30(4):574-581.
[10] Farquharson C,Lester D,Seawright E, et al. Microtubules are potential regulators of growth-plate chondrocyte differentiation and hypertrophy.[J]. Bone, 1999, 25(4):405.
[11] Edouard T,Cartault A. Gonadal function in Noonan syndrome[J]. Ann Endocrinol,2022,83(3):203-206.
[12] Pavone P,Marino S,Maniaci A,et al. Aarskog-Scott syndrome: Clinical and molecular characterisation of a family with the coexistence of a novel FGD1 mutation and 16p13.11-p12.3 microduplication[J]. BMJ Case Rep,2020,13(6):e235183.
[13] Hamzen AR, Saif F, Nair P, et al. A novel, putatively null, FGD1 variant leading to Aarskog-Scott syndrome in a family from UAE[J]. BMC Pediatr,2017,17(1). 31.
[14] Lima AR,Ferreira BM,Zhang CF, et al. Phenotypic and mutational spectrum of ROR2-related Robinow syndrome[J]. Hum Mut,2022, 43(7):900-918.
[15] Kanai Y, Koopman P. Structural and functional characterization of the mouse Sox9 promoter: Implications for campomelic dysplasia[J]. Hum Mol Genet,1999,8(4):691-696.
[16] Antwi P,Hong CS,Duran D,et al. A novel association of campomelic dysplasia and hydrocephalus with an unbalanced chromosomal translocation upstream of SOX9[J]. Cold Spring Harb Mol Case Stud,2018,4(3):a002766.
[17] Rona MR, Ben PS, Asaf V,et al. Kidney and urinary tract findings among patients with Kabuki (make-up) syndrome[J]. Pediatr Nephrol, 2021,36(12):4009-4012.
[18] Ilgin GI, Alexander W, Julia S, et al. Single-cell transcription profiles in Bloom syndrome patients link BLM deficiency with altered condensin complex expression signatures[J]. Hum Mol Genet,2022, 31(13):2185-2193.
[19] Xue CY,Sameer JS,Nozomi T, et al, Bloom helicase mediates formation of large single-stranded DNA loops during DNA end processing[J]. Nat Commun, 2022, 13(1):2248.
[20] Esra I, Arican D, Tahir A, et al. A rare cause of syndromic short stature: 3M syndrome in three families[J]. Am J Med Genet A,2021,185(2):461-468.
[21] Paiva KBS,Granjeiro J. Bone tissue remodeling and development: Focus on matrix metalloproteinase functions[J]. Arch Biochem Biophys,2014,561:74-87.
[22] Melrose J, Shu C, Whitelock JM, et al. The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation[J]. Matrix Bio, 2016,52-54:363-383.
[23] Wei X, Hu M, Mishina Y, et al. Developmental regulation of the growth plate and cranial synchondrosis[J]. J Dent Res,2016,95(11):1221-1229.
[24] Asude AD, Emin K, Urszula D, et al. Evolution of genetic techniques: Past, present, and beyond[J]. Biomed Research Int, 2015,2015:461524.
[25] Sharma A, Kumar GA, Chattopadhyay A. Late endosomal/lysosomal accumulation of a neurotransmitter receptor in a cellular model of Smith-Lemli-Opitz syndrome[J]. Traffic, 2021,22(10):332-344.
[26] Rozdzynska-swiatkowska A, Ciara E, Halat-Wolska P, et al. Anthropometric characteristics of 65 Polish Smith-Lemli-Opitz patients[J]. J Appl Genet,2021,62(3):469-475.
[27] Fuqua JS, Derr M, Rosenfeld,RG, et al. Identification of a novel heterozygous IGF1 splicing mutation in a large kindred with familial short stature[J]. Horm Res Paediatr,2012,78(1):59-66.
[28] Andrew D, Marie TM, Vicente B, et al. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability[J]. EMBO Mol Med,2016,8(4):363-374.
[29] Chan, YL, Salerm,Hsu YH, et al. Genome-wide analysis of body proportion classifies height-associated variants by mechanism of action and implicates genes important for skeletal development[J]. Am J Hum Genet,2015,96(5):695-708.